Charles Schwab Investment Management Inc Fulgent Genetics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 210,211 shares of FLGT stock, worth $3.54 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
210,211
Previous 245,188
14.27%
Holding current value
$3.54 Million
Previous $5.33 Million
27.1%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding FLGT
# of Institutions
205Shares Held
16.6MCall Options Held
2.34MPut Options Held
13.4K-
Black Rock Inc. New York, NY3.92MShares$66.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.39MShares$23.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.27MShares$21.4 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.05MShares$17.6 Million0.0% of portfolio
-
State Street Corp Boston, MA794KShares$13.4 Million0.0% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $510M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...